Risk Factors for Carbapenem Resistance in Gram Negative Nosocomial Pneumonia: A Single Centre Prospective Cohort Study
Introduction: Gram Negative Bacilli (GNB) account for about 70% of Hospital Acquired Pneumonia (HAP), Ventilator Acquired Pneumonia (VAP) and Healthcare Associated Pneumonia (HCAP). Increasing use of carbapenems lead to infections caused by GNBs with therapeutically challenging ExtendedSpectrum...
Main Authors: | Swayambhu Banerjee, Renoy Henry, Sandeep Surendran, Abhiram Pillai, Rema Pai |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-02-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/14522/46709_CE_F[SK]_PF1(AG_OM)_PFA(SHU)_PB(AG_KM)_PN(KM).pdf |
Similar Items
-
Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae
by: Müge AYHAN, et al.
Published: (2020-12-01) -
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing <it>klebsiella pneumoniae</it> in patients on maintenance hemodialysis
by: Yang Chih-Chao, et al.
Published: (2012-09-01) -
Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
by: Katariina Koskinen, et al.
Published: (2021-02-01) -
Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
by: Hae Suk Cheong, et al.
Published: (2016-11-01) -
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy
by: Chih-Chao Yang, et al.
Published: (2014-11-01)